Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma
To the Editor Therapy for relapsed and refractory multiple myeloma (RRMM) has been revolutionized with the availability of chimeric antigen receptor T cell therapy (CAR-T)…
